SCHEMBL6925754

SCHEMBL6925754

CCCCCCC=CCCCOc1ccccc1C(=O)O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.59
MEN1 O00255 2/20 0.59
LMNA P02545 2/20 0.59
MAPT P10636 2/20 0.59
NR1I2 O75469 1/20 0.59
CHRM2 P08172 1/20 0.59
CYP3A4 P08684 1/20 0.59
ADRA2A P08913 1/20 0.59
OPRK1 P41145 1/20 0.59
HTR2B P41595 1/20 0.59
SLC6A3 Q01959 1/20 0.59
HDAC6 Q9UBN7 1/20 0.59
PTPN11 Q06124 4/20 0.56
ALDH1A1 P00352 3/20 0.55
PTK2B Q14289 1/20 0.55
KDM4E B2RXH2 2/20 0.52
RECQL P46063 1/20 0.52
NPSR1 Q6W5P4 2/20 0.51
PTPN1 P18031 1/20 0.50
NPC1 O15118 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2887745 1.00 KMT2A (0.59) KMT2AMEN1LMNAMAPTNR1I2
SCHEMBL7710667 0.97 KMT2A (0.63) KMT2AMEN1LMNAMAPTNR1I2
SCHEMBL6084916 0.97 KMT2A (0.63) KMT2AMEN1LMNAMAPTNR1I2
SCHEMBL6084911 0.97 KMT2A (0.63) KMT2AMEN1LMNAMAPTNR1I2
SCHEMBL7710661 0.97 KMT2A (0.63) KMT2AMEN1LMNAMAPTNR1I2
SCHEMBL27864903 0.97 KMT2A (0.63) KMT2AMEN1LMNAMAPTNR1I2
SCHEMBL28977382 0.97 KMT2A (0.63) KMT2AMEN1LMNAMAPTNR1I2
SCHEMBL3665313 0.88 KMT2A (0.74) KMT2AMEN1LMNAMAPTNR1I2
SCHEMBL527254 0.88 KMT2A (0.74) KMT2AMEN1LMNAMAPTNR1I2
SCHEMBL112985 0.88 KMT2A (0.74) KMT2AMEN1LMNAMAPTNR1I2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6514407-B2 For use as supports in separation or in preparation of enantiomers, by employing gaseous, liquid or supercritical chromatography, by electrophoresis, electrochromatography or by percolation processes through membranes INSTITUT FRANCAIS DU PETROLE (FR) 2003-02-04 US disclosed
US-20020058763-A1 Chloro-, hydroxy- and alkoxysilane derivatives of polysaccharides or oligosaccharides, polymerizable and cross-linkable, their synthesis and their use as sources of novel support materials INSTITUT FRANCAIS DU PETROLE (FR) 2002-05-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020058763-A1 Chloro-, hydroxy- and alkoxysilane derivatives of polysaccharides or oligosaccharides, polymerizable and cross-linkable, their synthesis and their use as sources of novel support materials SI, SORD, HAO2 KMT2A 2557/4885MEN1 4777/4885LMNA 2960/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.